Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes.
Natascha SchweighoferBernd GenserWinfried MaerzMarcus Edi KleberOlivia TrummerThomas R PieberBarbara Obermayer-PietschPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
According to their OCT1 genotype, some individuals with T2DM on metformin therapy might be prone to an increased risk of cardiovascular death.
Keyphrases